February 2, 2009 - Researchers at the Ohio State University Medical Center are using cardiac magnetic resonance imaging to assess the effects of a common treatment for sleep apnea on heart structure and function in otherwise healthy individuals.
The study authored by Ulysses Magalang, M.D. and Subha Raman, M.D. appears in the Journal of Clinical Sleep Medicine.
“Little data exists on continuous positive airway pressure’s therapeutic effects on the heart’s right side, so we are leveraging the advantages of imaging to see if the treatment helps these patients,” said Dr. Magalang, medical director of Ohio State’s Sleep Disorders Center.
Researchers found that continuous positive airway pressure therapy (CPAP) improves heart structure with improvements in the volume of the right ventricle. CPAP is administered by a device that delivers continuous positive airway pressure during sleep. The device encompasses a mask worn over the nose, tubing and a fan that delivers enough air pressure to keep the throat open, preventing obstruction of the airway, and reversing the negative consequences of sleep apnea on the heart.
“By getting clear pictures of the heart in these patients, we were able to better understand the cardiovascular consequences of obstructive sleep apnea. These results can be used to guide treatments to reduce death and disability due to heart disease,” said Dr. Raman, medical director of the cardiac magnetic resonance and computerized tomography program at Ohio State’s Richard M. Ross Heart Hospital.
Drs. Magalang and Raman recently collaborated on a study published in the journal Experimental and Clinical Endocrinology & Diabetes showing a possible link between sleep apnea and heart disease, which is the leading cause of death responsible for 29 percent of people worldwide. The researchers identified a substance that may prevent atherosclerosis.
For more information: www.osumc.edu


Related Content

News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Subscribe Now